Study of breast cancer returning in the same area
Part of Cancer clinical trials.
This trial is for people who have had breast cancer treatment (surgery and radiation) and are now being monitored for any return of the cancer in the breast or nearby lymph nodes. It looks at how often cancer comes back in the same area and what factors might affect that.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with invasive breast cancer (ductal or lobular type)
- Your hormone receptor status (ER, PR, HER2) is known
- You had surgery (mastectomy or lumpectomy) and radiation therapy
- You are on regular follow-up visits with your doctor
- You have not had breast cancer that spread to other parts of the body at the time of diagnosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares three treatment options for breast cancer that has come back in the chest or lymph nodes after previous radiation. It looks at adding hyperthermia (heating the tumor area) to re-irradiation, versus just re-irradiation or surgery alone, to see which offers better quality of life and survival with fewer side effects.
This study follows people who have had breast cancer come back in the same area after surgery. It looks at how well re-treatment works and helps doctors understand how to manage this type of recurrence.
This study tests giving a second round of radiation therapy to women whose breast cancer has come back in the same breast, at least 3 years after their first radiation. It may be an option for women 55 and older who have a small, local recurrence that can be removed with surgery.
This Phase 2 study tests whether giving targeted radiation again to the same breast can control a small, local breast cancer that came back after prior whole-breast radiation. It may help some patients avoid or delay further treatment for the breast while carefully checking safety.
This trial looks at how well “salvage” treatments work for breast cancer that has come back only in the local area (like the chest wall or nearby lymph nodes), without spreading to distant organs. It also tracks side effects to better understand the risks and benefits for patients who need additional treatment.
This study looks at how the biology of breast cancer might change when it comes back (recurrence) after initial treatment. By comparing samples from the first diagnosis and the recurrence, doctors hope to better understand how to treat future recurrences.
Hear when a new Locoregional Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.